##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Mar 31, 2025

Émilie Lecler  

Abstract

The pathogenesis of cancer has been significantly influenced by body fat, which has the capacity to affect a variety of biological processes. Chronic inflammation and insulin resistance are known to be exacerbated by excess body fat, particularly visceral adipose tissue, which can establish an optimal microenvironment for tumor cell proliferation and progression. Adipocytes generate hormones and cytokines that can induce cancer cell proliferation, angiogenesis, and metastasis. Furthermore, adipose tissue serves as a storage facility for environmental toxins and carcinogens, which may be released into the bloodstream during periods of metabolic duress or weight loss. Additionally, obesity-induced modifications in the metabolism of adipose tissue can result in the dysregulation of lipid signaling pathways, which in turn induces tumorigenesis.

##plugins.themes.bootstrap3.article.details##

Keywords

Body Fat, Adipose Tissue, Pathogenesis, Cancer, Causal Relationship

Supporting Agencies

No funding source declared.

References
Biskupiak, Z., Ha, V. V., Rohaj, A., & Bulaj, G. (2024). Digital Therapeutics for improving Effectiveness of pharmaceutical drugs and biological products: Preclinical and clinical studies supporting development of drug + digital combination therapies for chronic diseases. Journal of Clinical Medicine, 13(2), 403. DOI: https://doi.org/10.3390/jcm13020403

Calle, E. E., & Kaaks, R. (2004). Overweight, obesity, and cancer: Epidemiological evidence and proposed mechanisms. Nature Reviews Cancer, 4(8), 579–591. DOI: https://doi.org/10.1038/nrc1408

Deng, L., Zhang, L., Tan, X., & Yan, W. (2016). Adipokines and cancer cell migration: A new insight into the relationship between obesity and cancer. Cellular Physiology and Biochemistry, 40(5), 1067–1075. DOI: https://doi.org/10.1159/000452428

Dinani, A., & Sanyal, A. (2017). Nonalcoholic fatty liver disease: implications for cardiovascular risk. Cardiovascular Endocrinology, 6(2), 62–72. DOI: https://doi.org/10.1097/xce.0000000000000126

Giovannucci, E., Harlan, D. M., Archer, M. C., et al. (2010). Diabetes and cancer: A consensus report. CA: A Cancer Journal for Clinicians, 60(4), 207–221. DOI: https://doi.org/10.3322/caac.20066

Heilbronn, L. K., & Campbell, L. V. (2008). Adipokines: Implications for obesity and type 2 diabetes. Diabetes/Metabolism Research and Reviews, 24(2), 130–141. DOI: https://doi.org/10.1002/dmrr.828

Kaptoge, S., Di Angelantonio, E., Lowe, G., et al. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. The Lancet, 375(9709), 132–140. DOI: https://doi.org/10.1016/S0140-6736(9)61717-7

Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011). Molecular mechanisms linking obesity to cancer. Nature Reviews, 11(12), 886–895. DOI: https://doi.org/ 10.1038/nrc3174

Levy, E. M., Roberti, M. P., & Mordoh, J. (2011). Natural killer cells in human cancer: From biological functions to clinical applications. BioMed Research International, 2011(1). DOI: https://doi.org/10.1155/2011/676198

Liu, Y., Zhang, Z., & Hu, L. (2017). Leptin as a key regulator of cancer development: The role of leptin in tumor growth, metastasis, and drug resistance. Oncotarget, 8(49), 85849–85862. DOI: https://doi.org/10.18632/oncotarget.21839

Luca, T., Pezzino, S., Puleo, S., & Castorina, S. (2024). Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research. Journal of Translational Medicine, 22(1). DOI: https://doi.org/10.1186/s12967-024-05547-3

Săvulescu-Fiedler, I., Mihalcea, R., Dragosloveanu, S., Scheau, C., Baz, R. O., Caruntu, A., Scheau, A., Caruntu, C., & Benea, S. N. (2024). The Interplay between Obesity and Inflammation. Life, 14(7), 856. DOI: https://doi.org/10.3390/life14070856

Sivaprakasam, S., & Thangaraju, M. (2020). The role of adipokines in obesity-induced cancer development. Cancer Letters, 469, 99–107. DOI: https://doi.org/10.1016/j.canlet.2019.10.029

Stan, M. C., & Paul, D. (2024). Diabetes and cancer: a twisted bond. Oncology Reviews, 18. DOI: https://doi.org/10.3389/or.2024.1354549

Sung, H., Ferlay, J., Siegel, R. L., et al. (2017). Global cancer statistics 2017: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 67(2), 94–109. DOI: https://doi.org/10.3322/caac.21387

Wang, R., Li, H., Yang, X., Xue, X., Deng, L., Shen, J., Zhang, M., Zhao, L., & Zhang, C. (2018). Genetically obese human gut microbiota induces liver steatosis in Germ-Free mice fed on normal diet. Frontiers in Microbiology, 9. DOI: https://doi.org/10.3389/fmicb.2018.01602
How to Cite
Lecler, Émilie. (2025). Contribution of Body Fat to the Pathogenesis of Cancer. Science Insights, 46(3), 1761–1763. https://doi.org/10.15354/si.25.op257
Section
Opinion